Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Economou

Showing results (121-130 of 151) with videos related to

Pageof 16
Sort By:
American Journal of Ophthalmology|April 17, 2007
Surveillance of the eye and vision in clinical trials of CP-675,206 for metastatic melanomaBradley R Straatsma, Steven Nusinowitz, Tara A Young, et al.
Annals of Surgical Oncology|January 1, 1997
Transduction of murine and human tumors using recombinant adenovirus vectorsE M Toloza, K Hunt, A R Miller, et al.
Cancer Research|April 29, 2000
Immune deviation and Fas-mediated deletion limit antitumor activity after multiple dendritic cell vaccinations in miceA Ribas, L H Butterfield, B Hu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2011
CTLA4 blockade induces frequent tumor infiltration by activated lymphocytes regardless of clinical responses in humansRong Rong Huang, Jason Jalil, James S Economou, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 23, 2018
Characterization of Postinfusion Phenotypic Differences in Fresh Versus Cryopreserved TCR Engineered Adoptive Cell Therapy ProductsTheodore S Nowicki, Helena Escuin-Ordinas, Earl Avramis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 1998
Generation of melanoma-specific cytotoxic T lymphocytes by dendritic cells transduced with a MART-1 adenovirusL H Butterfield, S M Jilani, N G Chakraborty, et al.
Cancer Research|July 15, 1997
Genetic immunization for the melanoma antigen MART-1/Melan-A using recombinant adenovirus-transduced murine dendritic cellsA Ribas, L H Butterfield, W H McBride, et al.
Clinical Immunology (Orlando, Fla.)|June 16, 2010
MHC-I-restricted melanoma antigen specific TCR-engineered human CD4+ T cells exhibit multifunctional effector and helper responses, in vitroSwagatam Ray, Arvind Chhabra, Nitya G Chakraborty, et al.
Cancer Research|July 9, 1999
Alpha-fetoprotein-specific genetic immunotherapy for hepatocellular carcinomaC M Vollmer, F C Eilber, L H Butterfield, et al.
Cancer Research|September 15, 1999
p53 selective and nonselective replication of an E1B-deleted adenovirus in hepatocellular carcinomaC M Vollmer, A Ribas, L H Butterfield, et al.
Pageof 16

Showing results (121-130 of 151) with videos related to

Sort By:
Pageof 16
American Journal of Ophthalmology|April 17, 2007
Surveillance of the eye and vision in clinical trials of CP-675,206 for metastatic melanomaBradley R Straatsma, Steven Nusinowitz, Tara A Young, et al.
Annals of Surgical Oncology|January 1, 1997
Transduction of murine and human tumors using recombinant adenovirus vectorsE M Toloza, K Hunt, A R Miller, et al.
Cancer Research|April 29, 2000
Immune deviation and Fas-mediated deletion limit antitumor activity after multiple dendritic cell vaccinations in miceA Ribas, L H Butterfield, B Hu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2011
CTLA4 blockade induces frequent tumor infiltration by activated lymphocytes regardless of clinical responses in humansRong Rong Huang, Jason Jalil, James S Economou, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 23, 2018
Characterization of Postinfusion Phenotypic Differences in Fresh Versus Cryopreserved TCR Engineered Adoptive Cell Therapy ProductsTheodore S Nowicki, Helena Escuin-Ordinas, Earl Avramis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 1998
Generation of melanoma-specific cytotoxic T lymphocytes by dendritic cells transduced with a MART-1 adenovirusL H Butterfield, S M Jilani, N G Chakraborty, et al.
Cancer Research|July 15, 1997
Genetic immunization for the melanoma antigen MART-1/Melan-A using recombinant adenovirus-transduced murine dendritic cellsA Ribas, L H Butterfield, W H McBride, et al.
Clinical Immunology (Orlando, Fla.)|June 16, 2010
MHC-I-restricted melanoma antigen specific TCR-engineered human CD4+ T cells exhibit multifunctional effector and helper responses, in vitroSwagatam Ray, Arvind Chhabra, Nitya G Chakraborty, et al.
Cancer Research|July 9, 1999
Alpha-fetoprotein-specific genetic immunotherapy for hepatocellular carcinomaC M Vollmer, F C Eilber, L H Butterfield, et al.
Cancer Research|September 15, 1999
p53 selective and nonselective replication of an E1B-deleted adenovirus in hepatocellular carcinomaC M Vollmer, A Ribas, L H Butterfield, et al.
Pageof 16